Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Melanoma Stage IV”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01676779
What this trial is testing

MRNA Electroporated Autologous Dendritic Cells for Stage III/IV Melanoma

Who this might be right for
Malignant Melanoma Stage IIIMalignant Melanoma Stage IV
Universitair Ziekenhuis Brussel 88
Very early researchEnded earlyNCT03893019
What this trial is testing

MB-CART20.1 Melanoma

Who this might be right for
Melanoma (Skin)
Miltenyi Biomedicine GmbH 9
Early research (Phase 1)UnknownNCT03903458
What this trial is testing

Tinostamustine and Nivolumab in Advanced Melanoma

Who this might be right for
Malignant Melanoma
Markus Joerger 21
Early research (Phase 1)Study completedNCT00002980
What this trial is testing

Decitabine in Treating Patients With Melanoma or Other Advanced Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
California Cancer Consortium
Testing effectiveness (Phase 2)Study completedNCT00243061
What this trial is testing

AZD2171 in Treating Patients With Recurrent or Stage IV Melanoma

Who this might be right for
Acral Lentiginous Malignant MelanomaCiliary Body and Choroid Melanoma, Medium/Large SizeCiliary Body and Choroid Melanoma, Small Size+8 more
National Cancer Institute (NCI) 24
Post-approval studies (Phase 4)Ended earlyNCT01856023
What this trial is testing

HD IL-2 + Ipilimumab in Patients With Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
Clinigen, Inc. 29
Not applicableUnknownNCT01503827
What this trial is testing

Whole Brain Radiotherapy Following Local Treatment of Intracranial Metastases of Melanoma

Who this might be right for
Metastatic Melanoma
Melanoma and Skin Cancer Trials Limited 220
Testing effectiveness (Phase 2)Ended earlyNCT01307618
What this trial is testing

Vaccine Therapy With or Without Recombinant Interleukin-12 Followed by Daclizumab in Treating Patients With Metastatic Melanoma

Who this might be right for
Recurrent MelanomaStage IV Skin Melanoma
National Cancer Institute (NCI) 10
Testing effectiveness (Phase 2)Ended earlyNCT00615160
What this trial is testing

PTK/ZK in Disseminated Malignant Melanoma

Who this might be right for
Melanoma
Michael Weichenthal 9
Testing effectiveness (Phase 2)WithdrawnNCT00085579
What this trial is testing

Interleukin-2 and Sargramostim After Chemotherapy in Treating Patients With Stage III or Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Study completedNCT04812470
What this trial is testing

Hepatic Arterial Infusion of Autologous Tumor Infiltrating Lymphocytes in Patients With Melanoma and Liver Metastases

Who this might be right for
Metastatic Uveal MelanomaMetastatic Cutaneous Melanoma
Vastra Gotaland Region 8
Testing effectiveness (Phase 2)Looking for participantsNCT05909618
What this trial is testing

Crizanlizumab Alone or in Combination With Nivolumab for Glioblastoma and Melanoma With Brain Metastases

Who this might be right for
Advanced GlioblastomaMetastatic Melanoma in the Central Nervous SystemMGMT-Unmethylated Glioblastoma
Sheba Medical Center 33
Testing effectiveness (Phase 2)Ended earlyNCT00402662
What this trial is testing

Everolimus in Combination With Imatinib in Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
Yale University 3
Testing effectiveness (Phase 2)WithdrawnNCT01933061
What this trial is testing

Study to Determine Efficacy and Safety of CC-486 With Nab-Paclitaxel Versus Nab-Paclitaxel in Patients With Chemotherapy naïve Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
Celgene Corporation
Testing effectiveness (Phase 2)Study completedNCT00483301
What this trial is testing

A Phase II Trial OF Carboplatin, ABI-007 (Abraxane) And Sorafenib (BAY 43-9006) in Metastatic Melanoma

Who this might be right for
Malignant Melanoma
Mt. Sinai Medical Center, Miami 34
Not applicableEnded earlyNCT03698162
What this trial is testing

Precise DCE-MRI in Diagnosing Participants With Recurrent High Grade Glioma or Melanoma Brain Metastases

Who this might be right for
Brain MetastasesGlioma of BrainBrain Tumor+1 more
University of Southern California 15
Testing effectiveness (Phase 2)Study completedNCT01973322
What this trial is testing

Vaccination With Autologous Dendritic Cells Loaded With Autologous Tumor Lysate or Homogenate Combined With Immunomodulating Radiotherapy and/or Preleukapheresis IFN-alfa in Patients With Metastatic Melanoma: a Randomized "Proof-of-principle" Phase II Study

Who this might be right for
Malignant Melanoma of Skin Stage IIIMalignant Melanoma of Skin Stage IV
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 34
Early research (Phase 1)Study completedNCT02857270
What this trial is testing

LY3214996 Administered Alone or in Combination With Other Agents in Participants With Advanced/Metastatic Cancer

Who this might be right for
Advanced CancerMetastatic MelanomaMetastatic Non-small Cell Lung Cancer+1 more
Eli Lilly and Company 210
Testing effectiveness (Phase 2)Study completedNCT01009177
What this trial is testing

Effect of Bosentan in Patients With Metastatic Melanoma Treated With Dacarbazine (DTIC)

Who this might be right for
Melanoma
Actelion 80
Testing effectiveness (Phase 2)Study completedNCT01659151
What this trial is testing

Vemurafenib With Lymphodepletion Plus Adoptive Cell Transfer & High Dose IL-2 Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
H. Lee Moffitt Cancer Center and Research Institute 17
Next Page